Plasma VEGF levels also appear to correlate with reduction in the tumor volume secondary to drug treatment, however, we found no correlation between peripheral blood mononuclear CD133 mRNA levels and plasma VEGF levels. The gene discussed is PROM1; the disease is neoplasm.